Ken Griffin acquired 187 Thousand Summit Therapeutics shares worth $4.62 Million. That's 0.00% of their equity portfolio (1637th largest holding). The first Summit Therapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares five more times and sold shares on eight occasions. The stake costed the investor $2.6 Million, netting the investor a gain of 78% so far.